From: "Bachman, William (MYD)"
Subject: [NMusers] Addresses for Globomax NONMEM and PDx-Pop Support Date: 11/3/2003 8:05 PM As many of you know, GloboMax has been acquired by Icon Clinical Trials. As a result of the acquisition, there have been no changes to the GloboMax infrastructure that will affect NONMEM and PDx-Pop licensing and suppport. We are also looking forward to continuing our research and development efforts to continually improve both PDx-Pop and NONMEM. The support email addresses remain: NONMEM - email@example.com PDx-Pop - firstname.lastname@example.org nmusers: to post to the list - email@example.com to be added or removed from the list firstname.lastname@example.org Individuals addressses at GloboMax - @globomax.com has changed to @iconus.com William J. Bachman, Ph.D. Manager, Pharmacometrics Research and Development GloboMax® The Strategic Pharmaceutical Development Division of ICON plc 7250 Parkway Drive, Suite 430 Hanover, MD 21076 410-782-2212 email@example.com _______________________________________________________